Mizuho Securities Upgrades Myriad Genetics (MYGN) to Buy
Tweet
Share
E-mailGet Alerts MYGN Hot Sheet
Price: $4.14 +7.25%
Rating Summary:
6 Buy, 19 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 10 | New: 43
Rating Summary:
6 Buy, 19 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 10 | New: 43
Join SI Premium – FREE
Mizuho Securities upgraded Myriad Genetics (NASDAQ: MYGN) from Neutral to Buy with a price target of $34.00 (from $27.00).
For an analyst ratings summary and ratings history on Myriad Genetics click here. For more ratings news on Myriad Genetics click here.
Shares of Myriad Genetics closed at $28.30 yesterday.
For an analyst ratings summary and ratings history on Myriad Genetics click here. For more ratings news on Myriad Genetics click here.
Shares of Myriad Genetics closed at $28.30 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dollarama Inc. (DOL:CN) (DLMAF) PT Raised to Cdn$236 at Bernstein SocGen Group
- Dollarama Inc. (DOL:CN) (DLMAF) PT Lowered to Cdn$217 at TD Securities
- Citi upgrades Haemonetics to Buy, raises price target to $123
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
